
CasCure Therapeutics Inc. is focused on developing truly personalized chemotherapy technology, leveraging artificial intelligence and deep learning to create precision cancer medicines. Founded on June 30, 2020, the company operates from its headquarters at the Ulsan Institute of Science and Technology and has a dedicated R&D center in Magok, Seoul. With a commitment to innovation in cancer treatment, CasCure aims to provide tailored solutions for medical professionals, positioning itself as a leader in the personalized medicine market.

CasCure Therapeutics Inc. is focused on developing truly personalized chemotherapy technology, leveraging artificial intelligence and deep learning to create precision cancer medicines. Founded on June 30, 2020, the company operates from its headquarters at the Ulsan Institute of Science and Technology and has a dedicated R&D center in Magok, Seoul. With a commitment to innovation in cancer treatment, CasCure aims to provide tailored solutions for medical professionals, positioning itself as a leader in the personalized medicine market.